Table 3.

Characteristics of each MSI-high sample in endometrioid type adenocarcinomas

Patient No.	Age at diagnosis (y)	Characteristics			No. of positive MSI markers
		Tumour grade (G)	FIGO stage	Myometrial invasion (%)*
1	71	G2	IA	No	2/5
2	68	G2	IA	No	4/5
3	54	G1	IA	No	3/5
4	74	G2	IA	< 50	4/5
5	72	G1	IA	< 50	2/5
6	61	G2	IA	< 50	5/5
7	63	G2	IA	< 50	2/5
8	72	G2	IB	≥ 50	3/5
9	67	G2	IB	≥ 50	2/5
10	58	G2	IB	≥ 50	3/5
11	80	G2	IB	≥ 50	2/5
12	66	G2	IB	≥ 50	3/5
13	73	G3	IB	≥ 50	2/5
14	61	G2	IB	≥ 50	4/5
15	63	G2	IIIC	≥ 50	4/5
16	53	G3	IIIC	≥ 50	4/5
17	61	G2	IVB	≥ 50	3/5

^*No – invasion only in endometrium